Exchange: NASDAQ·Updated 07:30 PM EST

INNV News

News
all
press releases
InnovAge (NASDAQ:INNV) Stock Price Down 7.1% - Time to Sell?
InnovAge (NASDAQ:INNV) Stock Price Down 7.1% - Here's Why...
MarketBeat
InnovAge (NASDAQ:INNV) Stock Price Down 7.1% - Time to Sell?
InnovAge (NASDAQ:INNV) Stock Price Down 7.1% - Here's Why...
MarketBeat
More News
Zacks Research raised shares of InnovAge from a "hold" rating to a "strong-buy" rating in a report on Monday...
MarketBeat
InnovAge (INNV) delivered earnings and revenue surprises of +27.27% and +3.74%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
InnovAge Holding (NASDAQ:INNV) reported first-quarter financial results on Tuesday. The transcript from the company's first-quarter earnings call has been provided below.This transcript is brought to you by Benzingaread more...
Benzinga
Pediatrix Medical Group (MD) delivered earnings and revenue surprises of +14.29% and +1.79%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
Caris Life Sciences, Inc. (CAI) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Zacks
Gainers Modular Medical (NASDAQ:MODD) shares increased by 11.3% to $3.14 during Wednesday's pre-market session. The market value of their outstanding shares is at $22.9 million. InnovAge Holding (NASDAQ:INNV)read more...
Benzinga
InnovAge shares climbed 10.25% after hours after fourth-quarter revenue beat estimates and the company issued fiscal 2027 guidance.read more...
Benzinga
InnovAge Holding (NASDAQ:INNV) reported fourth-quarter financial results on Tuesday. The transcript from the company's fourth-quarter earnings call has been provided below. This transcript is brought to you byread more...
Benzinga
InnovAge (INNV) delivered earnings and revenue surprises of -33.33% and +9.90%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks

Advertisement|Remove ads.